Locations:

Tag: robert abouassaly

May 20, 2022/Cancer

Real-World Study Supports IsoPSA as a Prostate Cancer Biomarker

Reflex testing led to substantially fewer provider recommendations for prostate biopsy and MRI

March 4, 2021/Cancer

Improved HIFU Technology Enables Promising Outcomes in Lower-Risk Prostate Cancer Patients

What’s ahead in the Focal Therapy Program at Cleveland Clinic

February 19, 2019/Cancer

BCG Shortages Affect Bladder Cancer Care Decisions

Study highlights need for mitigation strategies

May 20, 2018/Cancer

Quality Metrics for Bladder Cancer Surgery that Actually Measure Up

Meaningful scoring system correlates quality metrics and patient mortality

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

April 2, 2018/Cancer

FDA Approval of Apalutamide: Practical Implications

The first approved treatment for men with nonmetastatic castration-resistant prostate cancer (M0CRPC)

BackPage 1 of 1Next